This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Join this FREE, 75-minute online webinar to gain access to insights and learn about ground-breaking treatments to chronic mental health conditions. FREE WEBINAR: Helping to change policy – Influencing the TGA with Professor David Nutt (UK) What we know, what we think, and what we need to research Psychedelic […]
One of the ways we are achieving this is through our MDT webinar series. The lively discussion highlighted how effective cannabis can be for managing not only pain , but also the often accompanying conditions of anxiety , low mood , and poor sleep. Showcasing medical cannabis in a real world setting.
She began researching MDMA in 2004 and has worked on studies of psychedelics and mental health conditions at universities, NIH, and MAPS. She is an activist working to end the War on Drugs and advocates for science and reality-based drug education and harm reduction approaches for all.
We’ve put together a list of exceptional Michigan pain consultants to help complement your MMJ treatment. The team specializes in pain management, debilitating conditions, interventional and pharmacological pain management, rehabilitation, ketamine infusion therapy and more. Their philosophy: chronic pain needs chronic treatment.
CBD Essentials and Applications and Condition-Specific Treatment round out the current course offerings although new content modules are continually being added to the fourth course. By contrast, Cannabis Training University offers multiple single certifications based on different program completions.
Brimberry—who also leads Texas Cannabis Clinic—hosts monthly educational webinars on the Compassionate Use Program and how physicians can start prescribing medical cannabis. Since launching the webinar program, TXOG and Dr. Brimberry have trained more than 250 medical professionals.
People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating.
People with health conditions for which early research into CBG is showing favorable results, with support and direction from their healthcare providers. As research grows we’ll learn more about the therapeutic potential of CBG in infectious conditions. People who find CBD and/or CBDA too mentally stimulating.
Read on to explore seven common environmental impacts affecting cannabis cultivators and processors, as well as opportunities to effectively manage those impacts, and join us for our upcoming webinar to learn more. Pesticide Misuse.
With a population of 8,882,190, in 2013, New Jersey launched a Medical Marijuana Program presently comprised of 100,000 patients/caregivers serviced by 12 vertically integrated grower-processor-dispensaries (“Alternative Treatment Centers” or “ATCs”) administered by the Department of Health (“DOH”). 24:6I Et Seq. Compassionate Use Act”).
In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Interested parties may submit questions for regulators in advance of the NJ Department of Health webinar on August 2.If By: Kristin Jordan , Senior Counsel. Criterion 6.
In New Jersey, there are nearly 50,000 registered medical marijuana patients and only six Alternative Treatment Centers (ATCs) currently operating. Interested parties may submit questions for regulators in advance of the NJ Department of Health webinar on August 2.If By: Kristin Jordan , Senior Counsel. Kristin Jordan. Criterion 6.
Rylie will address the CannaTech community on a webinar on May 25. Today, Rylie’s focus with her team is to supply quality medical full-spectrum cannabis oil to all generations looking for holistic relief of various debilitating health conditions. Register for Rylie’s webinar May 25. I want to help.
I recently teamed up with my colleagues Hilary Bricken and Griffen Thorne to put on a free webinar answering all of your pressing questions about cannabis legal issues in California. The FTC has issued warning letters to companies that advertise their CBD-infused products as treatments or cures for serious medical conditions.
On January 6, 2022, DEA issued a letter that responded to a specific query on the treatment of cannabis seeds. CBP can make a demand for redelivery within thirty days after the goods were released or after the conditional release period, whichever is later. on a dry weight basis.
We’ve got a really interesting webinar coming up later this month on February 24. And we’re going to be focusing on Black-owned and social equity-focused brands on that webinar, so be sure to sign up and tune in. So, I’m legitimately, I’m a strength conditioning coach. We do a monthly product showcase.
Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. EG: Yeah, I was also very excited, we’ve done a number of different collaborations with Otha in the past year and a half, had him on webinars.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content